For solubility enhancement screens and formulation development, TSRL has partnered with Velesco Pharmaceutical Services, a firm that was founded in 2007 by former pharmaceutical R&D colleagues and is focused on early stage pharmaceutical development.

• Solubility enhancement
• Controlled release delivery
• Formulation scale-up
• Drug product stability

For early toxicology screening, TSRL has partnered with Research Essential Services, a firm that was founded in 2007 by former pharmaceutical R&D colleagues with laboratories in the Michigan Life Science and Innovation Center.

• Exploratory toxicology

To address toxicology and strategic considerations for the Discovery to Development transition of new small molecules and biologics, TSRL has partnered with Michigan Technology & Research Institute (MITRI). MITRI was established in 2006 by experienced drug development scientists, and assists companies in reaching critical decision points, IND filing, and proof-of-concept.